GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » ROA %

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) ROA % : 0.75% (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Wanbangde Pharmaceutical Holding Group Co's annualized Net Income for the quarter that ended in Sep. 2024 was ¥32 Mil. Wanbangde Pharmaceutical Holding Group Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥4,295 Mil. Therefore, Wanbangde Pharmaceutical Holding Group Co's annualized ROA % for the quarter that ended in Sep. 2024 was 0.75%.

The historical rank and industry rank for Wanbangde Pharmaceutical Holding Group Co's ROA % or its related term are showing as below:

SZSE:002082' s ROA % Range Over the Past 10 Years
Min: 1.16   Med: 4.12   Max: 7.4
Current: 2.35

During the past 13 years, Wanbangde Pharmaceutical Holding Group Co's highest ROA % was 7.40%. The lowest was 1.16%. And the median was 4.12%.

SZSE:002082's ROA % is ranked better than
52.2% of 1044 companies
in the Drug Manufacturers industry
Industry Median: 1.815 vs SZSE:002082: 2.35

Wanbangde Pharmaceutical Holding Group Co ROA % Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co ROA % Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.40 5.29 3.32 2.17 1.16

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.52 5.18 2.65 0.81 0.75

Competitive Comparison of Wanbangde Pharmaceutical Holding Group Co's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Wanbangde Pharmaceutical Holding Group Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wanbangde Pharmaceutical Holding Group Co's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wanbangde Pharmaceutical Holding Group Co's ROA % distribution charts can be found below:

* The bar in red indicates where Wanbangde Pharmaceutical Holding Group Co's ROA % falls into.



Wanbangde Pharmaceutical Holding Group Co ROA % Calculation

Wanbangde Pharmaceutical Holding Group Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=49.209/( (4218.157+4296.358)/ 2 )
=49.209/4257.2575
=1.16 %

Wanbangde Pharmaceutical Holding Group Co's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=32.008/( (4321.708+4268.452)/ 2 )
=32.008/4295.08
=0.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=32.008/4295.08
=(Net Income / Revenue)*(Revenue / Total Assets)
=(32.008 / 1286.772)*(1286.772 / 4295.08)
=Net Margin %*Asset Turnover
=2.49 %*0.2996
=0.75 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Wanbangde Pharmaceutical Holding Group Co ROA % Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co Headlines

No Headlines